PAIELLA, Salvatore
 Distribuzione geografica
Continente #
EU - Europa 9.007
NA - Nord America 8.852
AS - Asia 5.805
SA - Sud America 961
AF - Africa 168
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.818
Nazione #
US - Stati Uniti d'America 8.658
RU - Federazione Russa 3.552
SG - Singapore 2.290
CN - Cina 1.880
GB - Regno Unito 1.327
IT - Italia 1.151
BR - Brasile 810
HK - Hong Kong 694
DE - Germania 665
SE - Svezia 529
IE - Irlanda 491
FR - Francia 465
VN - Vietnam 315
FI - Finlandia 262
NL - Olanda 169
KR - Corea 164
CA - Canada 107
IN - India 86
JP - Giappone 86
UA - Ucraina 74
MX - Messico 65
AR - Argentina 64
AT - Austria 52
PL - Polonia 50
TR - Turchia 48
ES - Italia 46
ID - Indonesia 44
CZ - Repubblica Ceca 39
TG - Togo 38
ZA - Sudafrica 36
BD - Bangladesh 35
BE - Belgio 33
BJ - Benin 33
IQ - Iraq 31
PK - Pakistan 21
LT - Lituania 20
EC - Ecuador 18
AU - Australia 17
CO - Colombia 17
PY - Paraguay 15
UZ - Uzbekistan 15
IR - Iran 13
IL - Israele 12
MA - Marocco 11
TN - Tunisia 11
VE - Venezuela 11
EG - Egitto 10
CH - Svizzera 9
CL - Cile 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
AZ - Azerbaigian 8
DK - Danimarca 7
JO - Giordania 7
KG - Kirghizistan 7
SA - Arabia Saudita 7
GR - Grecia 6
HU - Ungheria 6
KE - Kenya 6
PE - Perù 6
BG - Bulgaria 5
HR - Croazia 5
LV - Lettonia 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
BO - Bolivia 4
GH - Ghana 4
KZ - Kazakistan 4
LB - Libano 4
NP - Nepal 4
PA - Panama 4
PT - Portogallo 4
RO - Romania 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
GA - Gabon 3
GE - Georgia 3
GY - Guiana 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
RS - Serbia 3
TH - Thailandia 3
UG - Uganda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DZ - Algeria 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MK - Macedonia 2
OM - Oman 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
Totale 24.796
Città #
Dallas 2.253
Moscow 1.378
Southend 1.107
Chandler 1.085
Singapore 886
Hong Kong 692
Ashburn 678
Dublin 470
Beijing 383
Verona 341
New York 249
Woodbridge 239
Jacksonville 227
Munich 227
Los Angeles 217
Houston 193
Ann Arbor 169
Lawrence 150
Princeton 150
Boardman 137
Wilmington 133
Helsinki 124
Ho Chi Minh City 121
Jinan 115
The Dalles 100
Nanjing 94
Shenyang 90
Redondo Beach 87
São Paulo 86
Buffalo 82
Santa Clara 79
Sindelfingen 75
Seattle 74
Tokyo 70
Milan 65
Hanoi 64
London 63
Turku 63
Columbus 62
Redmond 61
Tianjin 56
Hebei 55
Hangzhou 49
Amsterdam 45
Montreal 45
Fairfield 43
Denver 42
Haikou 42
Ningbo 40
Changsha 38
Council Bluffs 38
Lomé 38
Warsaw 38
Bologna 37
Nuremberg 37
Zhengzhou 37
Brooklyn 35
San Francisco 35
Atlanta 34
Falkenstein 34
Frankfurt am Main 34
Redwood City 34
Seoul 34
Chicago 33
Cotonou 33
Guangzhou 33
Phoenix 33
Washington 33
Nanchang 32
Stockholm 32
Toronto 32
Brussels 31
Orem 31
Brno 30
Chennai 30
Rome 30
Taizhou 29
Lappeenranta 28
Taiyuan 28
Johannesburg 25
Meda 25
Mexico City 25
Belo Horizonte 24
Falls Church 24
Vienna 24
Rio de Janeiro 23
Boston 22
Jiaxing 22
Poplar 22
Jakarta 21
Manchester 20
Norwalk 18
Brasília 17
Charlotte 16
Kent 16
Fuzhou 15
Curitiba 14
Da Nang 14
Dongguan 14
Lancaster 14
Totale 14.772
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 500
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 367
Assessment of Psychological Burden in Individuals with Hereditary Risk of Pancreatic Cancer Under Surveillance: Evaluation of Distress 3 Years After Enrollment 294
Addressing Pancreatic Exocrine Insufficiency and the Impact of Pancreatic Enzyme Replacement Therapy Shortages in Europe 271
Diffusion of Robotic Platforms and New Devices in HPB Surgery: A European-African Hepato-Pancreato-Biliary Association (E-AHPBA) Survey 235
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature 226
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 212
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 202
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 199
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 199
7T MRI and histology reveal early tissue and perfusion changes after radiofrequency ablation in a murine colorectal cancer model 197
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 196
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 195
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 195
Gα15 in early onset of pancreatic ductal adenocarcinoma 192
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 190
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 189
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 182
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 179
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 176
A root-cause analysis of mortality following major pancreatectomy 176
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 174
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 172
Delaying surgery for patients with a previous SARS-CoV-2 infection 169
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 168
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 167
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 162
Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study 162
Results of a surveillance protocol for pancreatic BD-IPMNs 161
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 161
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 158
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 155
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 155
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 155
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 153
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 152
Cytoreduction after radiofrequency ablation of unresectable pancreatic adenocarcinoma: correlation between CA 19.9 serum levels and necrosis extent at CT 151
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 150
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 150
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 150
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 148
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 147
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 146
Minimally invasive pancreatic surgery - a review 145
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 144
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 142
Ablation treatments in unresectable pancreatic cancer 141
Use of an intraoperative wound protector to prevent surgical-site infection after pancreatoduodenectomy: randomized clinical trial 141
Can CT texture analysis predict resectability and surgical outcomes after neoadjuvant radiotherapy in pancreatic cancer patients? 141
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 141
Fhit down-regulation is an early event in pancreatic carcinogenesis 140
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 140
The management of intraductal papillary mucinous neoplasms of the pancreas 139
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 138
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 136
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 136
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 135
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 135
Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results 134
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 134
Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation 133
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer 133
Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers 133
Dental plaque microbiota sequence counts for microbial profiling and resistance genes detection 132
Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma 132
Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a Studies 132
Endoscopic Ultrasound Features Associated with Malignancy and Aggressiveness of Nonhypovascular Solid Pancreatic Lesions: Results from a Prospective Observational Study 131
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) 130
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 129
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 129
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 129
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 129
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 128
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial 128
Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: International multicenter retrospective study 128
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis 127
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 127
Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors 125
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 125
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 124
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 123
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 122
Computed tomography-based radiomic to predict resectability in locally advanced pancreatic cancer treated with chemotherapy and radiotherapy 122
Percutaneous ablation of pancreatic cancer 121
Erratum: The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging 121
Sex differences in oncogenic mutational processes 121
The emotional impact of surveillance programs for pancreatic cancer on high-risk individuals: A prospective analysis 120
Solid-pseudopapillary, Acinar, and Other Cystic Neoplasms 118
Surveillance for Pancreatic Cancer in High-Risk Individuals: First-Round Screening Results of a Multicentric Italian Program 118
The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging 118
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 117
ESGAR 2018 Book of Abstracts 117
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 117
Robotic Dual-Console Distal Pancreatectomy: Could it be Considered a Safe Approach and Surgical Teaching even in Pancreatic Surgery? A Retrospective Observational Study Cohort 117
401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience 117
Radiofrequency Ablation of Pancreatic Cancer 116
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 116
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar 116
Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial 116
Le terapie ablative delle neoplasie pancreatiche 115
Totale 15.552
Categoria #
all - tutte 91.368
article - articoli 86.832
book - libri 0
conference - conferenze 1.626
curatela - curatele 0
other - altro 251
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.659
Totale 182.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021615 0 0 0 0 139 121 48 36 60 41 94 76
2021/20221.147 123 256 12 75 45 43 46 69 75 36 87 280
2022/20233.444 187 400 251 573 283 964 96 214 335 34 62 45
2023/20241.995 56 144 201 219 204 329 108 144 32 98 354 106
2024/20255.118 283 273 232 776 269 153 326 282 671 370 522 961
2025/20269.793 1.032 1.140 2.035 2.710 2.876 0 0 0 0 0 0 0
Totale 25.163